CATALANO, Alfonso
 Distribuzione geografica
Continente #
NA - Nord America 2.305
EU - Europa 1.318
AS - Asia 1.062
SA - Sud America 227
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 2
Totale 4.947
Nazione #
US - Stati Uniti d'America 2.265
SG - Singapore 353
VN - Vietnam 236
UA - Ucraina 231
RU - Federazione Russa 185
BR - Brasile 181
CN - Cina 180
IT - Italia 179
SE - Svezia 159
DE - Germania 136
IE - Irlanda 115
DK - Danimarca 88
HK - Hong Kong 82
FI - Finlandia 71
FR - Francia 69
TR - Turchia 65
KR - Corea 49
GB - Regno Unito 40
CA - Canada 18
MX - Messico 17
BE - Belgio 16
IN - India 16
AR - Argentina 13
BD - Bangladesh 13
ZA - Sudafrica 13
IQ - Iraq 12
JP - Giappone 11
EC - Ecuador 10
PL - Polonia 9
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
ES - Italia 6
ID - Indonesia 6
VE - Venezuela 6
CL - Cile 5
KE - Kenya 5
NL - Olanda 5
PK - Pakistan 5
SA - Arabia Saudita 5
CO - Colombia 4
DZ - Algeria 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
JO - Giordania 3
MY - Malesia 3
PY - Paraguay 3
TH - Thailandia 3
EU - Europa 2
GT - Guatemala 2
MA - Marocco 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BH - Bahrain 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DM - Dominica 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
KZ - Kazakistan 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
Totale 4.947
Città #
Chandler 257
Singapore 241
Jacksonville 229
Ashburn 196
Fairfield 166
Des Moines 129
Boardman 118
Dublin 115
Hong Kong 77
Ho Chi Minh City 76
Woodbridge 76
Wilmington 74
Ann Arbor 73
New York 70
San Jose 69
Dallas 66
The Dalles 60
Hanoi 55
Houston 55
Princeton 47
Lawrence 46
San Mateo 45
Cambridge 43
Beijing 41
Lauterbourg 40
Seattle 40
Hefei 30
Centro 29
Moscow 28
Los Angeles 25
San Diego 22
Munich 19
Helsinki 18
São Paulo 17
Brussels 15
Buffalo 12
Rio de Janeiro 12
Da Nang 11
Haiphong 11
Orem 11
Rome 10
London 9
Tokyo 9
Frankfurt am Main 8
Santa Clara 8
Warsaw 8
Atlanta 7
Porto 7
Tashkent 7
Turku 7
Wuhan 7
Abidjan 6
Belo Horizonte 6
Chicago 6
Council Bluffs 6
Milan 6
Mumbai 6
Mexico City 5
Nairobi 5
Toronto 5
Wuxi 5
Bari 4
Biên Hòa 4
Boston 4
Brooklyn 4
Bắc Ninh 4
Can Tho 4
Cape Town 4
Johannesburg 4
Manchester 4
Montreal 4
Pittsburgh 4
Quito 4
Shanghai 4
Turin 4
Washington 4
Amman 3
Bình Phước 3
Charlotte 3
Chennai 3
Contagem 3
Curitiba 3
Dhaka 3
Erbil 3
Guangzhou 3
Guarulhos 3
Isidro Casanova 3
Jakarta 3
Jeddah 3
Jiaxing 3
Naples 3
Ninh Bình 3
Norwalk 3
Ottawa 3
Palermo 3
Palo del Colle 3
Santiago 3
Uberaba 3
Vienna 3
Amsterdam 2
Totale 3.038
Nome #
Decitabine, differently from DNMT1 silencing, exerts its antiproliferative activity through p21 upregulation in Malignant Pleural Mesothelioma (MPM) cells. 160
Il Celecoxib sensibilizza le cellule tumorali di prostata alla morte cellulare recettore-mediata 159
HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma 155
USO FARMACEUTICO DI SEMAFORINE 153
Current perspectives between metabolic syndrome and cancer 147
5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation 142
FLIP overexpression inhibits death receptor-induced apoptosis in malignant mesothelial cells 141
Emerging Role of Stromal Fibroblasts in Epithelial Cancer 136
Adenovirus-mediated wild-type p53 overexpression reverts tumourigenicity of human mesothelioma cells 135
5-Lipoxigenase regulates malignant mesothelioma cell survival: involvement of vascular endothelial growth factor. 129
Angiogenesis and Mesothelioma 128
The Neuroimmune Semaphorin-3A Reduces Inflammation and Progression of Experimental Autoimmune Arthritis. 123
Transcriptionally active drugs improve adenovirus vector performance in vitro and in vivo 123
Integrin-mediated cell adhesion and spreading engage different sources of reactive oxygen species 119
Semaphorin3A signaling controls Fas (CD95)-mediated apoptosis by promoting Fas translocation into lipid rafts 117
Characterization of human malignant mesothelioma cell lines orthotopically implanted in the pleural cavity of immunodeficient mice for their ability to grow and form metastasis 117
Expression of basic fibroblast growth factor, its receptors and syndecans in bladder cancer. 113
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments 112
Iperespressione della 5-lipossigenasi nel carcinoma renale a cellule chiare. 112
Experimental therapy of malignant mesothelioma: new perspectives from anti-angiogenic treatments (Review). 108
Metronomic administration of zoledronic acid and taxotere combination in castration resistant prostate cancer patients: Phase I ZANTE trial. 107
Hyperglycemia promotes K-Ras-induced lung tumorigenesis through BASCs amplification 107
Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function 106
Increased expression of 5-lipoxygenase is common in clear cell renal carcinoma 103
5-lipoxygenase antagonizes genotoxic stress-induced apoptosis by altering p53 nuclear trafficking 103
Retinoids induce fibroblast growth factor-2 production in endothelial cells via retinoic acid receptor alpha activation and stimulate angiogenesis in vitro and in vivo 102
Semaphorins and their receptors in stem and cancer cells. 102
The plexin-A1 receptor activates vascular endothelial growth factor-receptor 2 and nuclear factor-κ B to mediate survival and anchorage-independent growth of malignant mesothelioma cells 100
Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. 99
Enhanced antitumor therapy by inhibition of p21waf1 in human malignant mesothelioma 98
Lipoxygenase inhibitors for cancer prevention: promises and risks 97
Induction of stem cell factor/c-Kit/slug signal transduction in multidrug-resistant malignant mesothelioma cells 97
Preclinical evaluation of the nonsteroidal anti-inflammatory agent celecoxib on malignant mesothelioma chemoprevention 95
Expression of glycoprotein 90K in human malignant pleural mesothelioma: correlation with patient survival 92
Basic fibroblast growth factor in mesothelioma pleural effusions: correlation with patient survival and angiogenesis 92
Oxidative Stress and Activation of Survival Pathways as a Basis for Mesothelioma Pathogenesis: New Perspectives for Experimental Therapy 91
New aspects on the role of lipoxygenases in cancer progression 85
Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation 85
Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment 82
semaphorins: a further chemotropic family expressed in the thymus 81
The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer 78
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-KB to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells 76
Neuronal semaphorins regulate a primary immune response 72
The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-{kappa}B to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells. 71
Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma 70
Methionine Aminopeptidase-2 regulates human mesothelioma cell survival: role on BCL-2 expression and telomerase activity 58
Totale 4.978
Categoria #
all - tutte 21.021
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.021


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021146 0 0 0 0 0 0 0 0 0 49 69 28
2021/2022373 23 124 0 23 5 21 15 17 23 28 30 64
2022/2023784 59 63 49 70 68 208 2 47 156 7 31 24
2023/2024364 71 10 29 58 59 67 3 4 3 8 7 45
2024/2025672 47 56 28 14 18 26 55 14 185 50 61 118
2025/20261.437 92 93 90 151 172 123 325 153 121 117 0 0
Totale 4.978